Ipsen has been given accelerated approval by the FDA for Iqirvo, which becomes the first dual PPAR alpha/delta agonist for rare cholestatic liver disease primary biliary cholangitis (PBC). Iqirvo ...

Phase II ELMWOOD trial shows elafibranor is well tolerated and improves liver biochemistry and pruritus in primary sclerosing ...

One out of every six people will die awaiting or become too ill to undergo an organ transplant in the United States. LaVale resident and first responder Dan ...

This is the first story in a two-part series about local resident and first responder Dan Carr’s recent liver transplant.

Clinically diagnosed pruritus significantly affected fatigue and antidepressant use in adults with primary sclerosing cholangitis (PSC), based on data from nearly 5000 patients presented at The Liver ...

Introduction: Retained appendicoliths are an uncommon but clinically relevant complication of appendectomy, particularly in cases of perforated appendicitis. Migration of the appendicolith into the ...

Ahead of New York Fashion Week, Gilead Sciences is strutting its marketing stuff to raise awareness of primary biliary cholangitis (PBC). The pharma—which earned the FDA’s accelerated approval for PBC ...

Although PSC has no cure, you can manage liver damage with early diagnosis and treatment. Here’s how PSC and UC are connected, and what you can do if you have both. Like UC, PSC is a chronic ...

Findings showed a statistically significantly greater proportion of saroglitazar-treated patients achieved a biochemical response vs placebo (treatment difference, 48.5%; P .001). Topline data were ...

Patients in the IgG4-relatd cholangitis group presented with significantly higher rates of obstructive jaundice compared with those in the other benign biliary strictures groups (73.7% vs 29.7%, ...

Once clinical suspicion has been established for primary biliary cholangitis (PBC), the "serologic hallmark" of the autoimmune disease are anti-mitochondrial antibodies (AMA), present in approximately ...

Cholangitis and cholecystitis are two conditions that share some similarities but have different causes and symptoms. Cholangitis affects the bile ducts, while cholecystitis affects the gallbladder.